EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada ...
NORTH FOND DU LAC, WI - April 02, 2026 - PRESSADVANTAGE - FZE Manufacturing has announced a significant expansion of ...
Tucking into roast lamb this Easter holliday with all the family? Christine Austin selects the best red wines you can buy off ...
Although many things can affect your individual prognosis, about half of all patients will reach kidney failure within 10 years of their diagnosis and need dialysis or a kidney transplant. Even after ...
The evaluation will compare AI-based predictions with actual rainfall and climate data, says IMD director general Mrutyunjay ...
C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare and progressive kidney diseases, caused by problems in the immune system. They are two distinct ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...
Results from CADENCE, the first and largest multinational prospective registry for patients with CAD/CAS, describe safety events observed in patients treated with sutimlimab, with an average treatment ...
Add Yahoo as a preferred source to see more of our stories on Google. Leaders of an effort to finance a $16.7 million renovation of Joplin’s Memorial Hall told residents during a Monday night ...
Leaders of an effort to finance a $16.7 million renovation of Joplin’s Memorial Hall told residents during a Monday night presentation that they were hoping to receive approval of a memorandum of ...
Low-complexity domains in proteins are composed of a small subset of the full complement of amino acids, and in these domains, the amino acid sequences are often repetitive. Their relevance to health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results